Should interventions aimed at improving health and alleviating suffering not be valued equally? Read more at The Business ...

The SURMOUNT-1 trial evaluated Tirzepatide a dual GIP/GLP1 agonist, in individuals with overweight (BMI more than or equal to ...

When a hospitalized patient can’t be weighed accurately or an imaging table won’t support their body size, the issue often ...

Agilus Diagnostics, one of India’s leading diagnostic service providers and a subsidiary of Fortis Healthcare, announced the ...

WHO has issued its first global guideline supporting the use of GLP-1 weight-loss medicines for long-term obesity care, ...

Mumbai, Dec 04: A new national survey by the Obesity and Metabolic Surgery Society of India (OSSI) has revealed serious gaps ...

Abdominal obesity, sometimes referred to as a “beer belly,” is associated with more harmful changes in heart structure than ...

Released December 1, 2025, this first-ever global guideline conditionally recommends these drugs for long-term adult obesity ...

SGMC Health’s podcast, What Brings You in Today?, has earned a Silver Award in the Podcast category from the Fall 2025 ...

Researchers who studied advanced cardiovascular MRI (magnetic resonance imaging) scans of 2,244 adults aged 46 to 78 without ...

Still, the findings reinforce what other research has suggested: thinness is not always protective, and extra weight is not ...

The end of the year is a time when parties and get-togethers are part of the festive season. This month, especially, your patients may ask about how they can stay on a wellness journey while still ...